查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1729480

日本生物材料市场报告（按类型（天然生物材料、金属生物材料、陶瓷生物材料、聚合物生物材料）、应用（神经病学、心臟病学、骨科、伤口护理、牙科、整形外科等）和地区）2025-2033

Japan Biomaterials Market Report by Type (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Wound Care, Dental, Plastic Surgery, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024 年，日本生物材料市场规模达 74.58 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 206.97 亿美元，2025-2033 年期间的成长率 (CAGR) 为 12%。心血管疾病、糖尿病和骨科疾病等慢性疾病病例的增加，以及对基于生物材料的医疗设备和疗法的需求的不断增长，是推动市场发展的主要因素。

生物材料是经过设计和製造以与生物系统相互作用的物质，通常用于医疗或治疗目的。这些材料有各种各样的应用，从人造器官和组织工程到药物传输系统和医疗植入物。生物材料可以是天然的、合成的或两者的组合，并且根据其与人体的兼容性进行精心选择。胶原蛋白和丝绸等天然生物材料源自生物来源，以其生物相容性而闻名。合成生物材料，如聚合物和陶瓷，具有强度和耐用性等特定特性。生物材料的选择取决于预期的功能和在体内的位置。生物材料在现代医学中发挥着至关重要的作用，推动了治疗和程序的进步。它们可以促进组织再生，提供结构支撑，并作为治疗剂的载体。然而，确保其安全性和有效性至关重要，因为它们进入人体后不能引起有害的免疫反应或不良反应。研究人员不断在生物材料领域进行创新，以增强医疗治疗并改善患者的治疗效果。

日本生物材料市场趋势：

日本生物材料市场正在经历强劲成长，主要受到几个相互关联的因素的推动。首先，心血管疾病、骨科疾病等慢性疾病的发生率不断上升，推动了医疗领​​域对生物材料的需求。此外，区域人口老化也加剧了这一趋势，因为老年人需要更多的医疗干预，而这些干预通常涉及生物材料。其次，技术进步显着提高了生物材料的多功能性和有效性。生物活性陶瓷、可生物降解聚合物和组织工程技术的发展扩大了生物材料的应用范围。第三，人们对传统材料对环境影响的认识不断提高，导致对永续生物材料的需求激增。随着消费者的环保意识不断增强，由可再生资源製成的生物材料（如植物性聚合物）在包装和汽车等各个行业中越来越受欢迎。最后，预计在预测期内，许多政府措施和法规将推动生物材料在医疗和工业用途的应用，进而推动日本生物材料市场的发展。

日本生物材料市场细分：

类型洞察：

  • 天然生物材料
  • 金属生物材料
  • 陶瓷生物材料
  • 聚合物生物材料

应用程式洞察：

  • 神经病学
  • 心臟病学
  • 骨科
  • 伤口护理
  • 牙科
  • 整型手术
  • 其他的
  • 报告还提供了基于应用的市场详细细分和分析。其中包括神经病学、心臟病学、骨科、伤口护理、牙科、整形外科等。

竞争格局：

市场研究报告也对市场竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本生物材料市场迄今表现如何？未来几年将如何表现？
  • COVID-19对日本生物材料市场有何影响？
  • 日本生物材料市场依类型分为哪些类型？
  • 日本生物材料市场按应用分類的状况如何？
  • 日本生物材料市场的价值链分为哪些阶段？
  • 日本生物材料的主要驱动因素和挑战是什么？
  • 日本生物材料市场的结构是怎么样的？主要参与者是谁？
  • 日本生物材料市场的竞争程度如何？

本报告回答的关键问题：

  • 日本生物材料市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本生物材料市场有何影响？
  • 日本生物材料市场依类型分为哪些类型？
  • 日本生物材料市场按应用分類的状况如何？
  • 日本生物材料市场的价值链分为哪些阶段？
  • 日本生物材料的关键驱动因素和挑战是什么？
  • 日本生物材料市场的结构是怎么样的？主要参与者是谁？
  • 日本生物材料市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本生物材料市场-简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本生物材料市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本生物材料市场-分类：依类型

  • 天然生物材料
    • 概述
  • 金属生物材料
    • 概述
  • 陶瓷生物材料
    • 概述
  • 聚合物生物材料
    • 概述

第七章：日本生物材料市场-细分：依应用

  • 神经病学
    • 概述
  • 心臟病学
    • 概述
  • 骨科
    • 概述
  • 伤口护理
    • 概述
  • 牙科
    • 概述
  • 整型手术
    • 概述
  • 其他的

第八章：日本生物材料市场-竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第九章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第十章：日本生物材料市场-产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 11 章：附录

简介目录
Product Code: SR112025A15512

Japan biomaterials market size reached USD 7,458 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 20,697 Million by 2033, exhibiting a growth rate (CAGR) of 12% during 2025-2033. The rising cases of chronic ailments, such as cardiovascular diseases, diabetes, and orthopedic disorders, and the increasing need for biomaterial-based medical devices and therapies, are primarily driving the market.

Biomaterials are substances designed and engineered to interact with biological systems, often for medical or therapeutic purposes. These materials are used in a variety of applications, from artificial organs and tissue engineering to drug delivery systems and medical implants. Biomaterials can be natural, synthetic, or a combination of both, and they are carefully selected based on their compatibility with the human body. Natural biomaterials, such as collagen and silk, are derived from biological sources and are known for their biocompatibility. Synthetic biomaterials, like polymers and ceramics, are tailored for specific properties like strength and durability. The choice of biomaterial depends on the intended function and location within the body. Biomaterials play a crucial role in modern medicine, enabling advancements in treatments and procedures. They can promote tissue regeneration, provide structural support, and serve as carriers for therapeutic agents. However, ensuring their safety and effectiveness is paramount, as they must not elicit harmful immune responses or adverse reactions when introduced into the body. Researchers continually innovate in the field of biomaterials to enhance medical treatments and improve patient outcomes.

Japan Biomaterials Market Trends:

The biomaterials market in Japan is witnessing robust growth, primarily driven by several interconnected factors. Firstly, the increasing cases of chronic diseases such as cardiovascular disorders and orthopedic ailments have propelled the demand for biomaterials in the medical field. Furthermore, an aging regional population is contributing to this trend, as older individuals require more medical interventions that often involve biomaterials. Secondly, technological advancements have significantly enhanced the versatility and effectiveness of biomaterials. This is exemplified by the development of bioactive ceramics, biodegradable polymers, and tissue engineering techniques, which have expanded the scope of biomaterial applications. Thirdly, the growing awareness of the environmental impact of traditional materials has led to a surge in demand for sustainable biomaterials. As consumers become more eco-conscious, biomaterials made from renewable sources, like plant-based polymers, gain traction in various industries, including packaging and automotive. Lastly, numerous government initiatives and regulations that are promoting the use of biomaterials for medical and industrial purposes, are expected to drive the biomaterials market in Japan during the forecast period.

Japan Biomaterials Market Segmentation:

Type Insights:

  • Natural Biomaterial
  • Metallic Biomaterial
  • Ceramic Biomaterial
  • Polymeric Biomaterial

Application Insights:

  • Neurology
  • Cardiology
  • Orthopedics
  • Wound Care
  • Dental
  • Plastic Surgery
  • Others
  • A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes neurology, cardiology, orthopedics, wound care, dental, plastic surgery, and others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan biomaterials market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan biomaterials market?
  • What is the breakup of the Japan biomaterials market on the basis of type?
  • What is the breakup of the Japan biomaterials market on the basis of application?
  • What are the various stages in the value chain of the Japan biomaterials market?
  • What are the key driving factors and challenges in the Japan biomaterials?
  • What is the structure of the Japan biomaterials market and who are the key players?
  • What is the degree of competition in the Japan biomaterials market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biomaterials Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Biomaterials Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Biomaterials Market - Breakup by Type

  • 6.1 Natural Biomaterial
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Metallic Biomaterial
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Ceramic Biomaterial
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Polymeric Biomaterial
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)

7 Japan Biomaterials Market - Breakup by Application

  • 7.1 Neurology
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Cardiology
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Orthopedics
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Wound Care
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Dental
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Plastic Surgery
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2019-2024)
    • 7.6.3 Market Forecast (2025-2033)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2019-2024)
    • 7.7.2 Market Forecast (2025-2033)

8 Japan Biomaterials Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 Company A
    • 9.1.1 Business Overview
    • 9.1.2 Product Portfolio
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 Company B
    • 9.2.1 Business Overview
    • 9.2.2 Product Portfolio
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Company C
    • 9.3.1 Business Overview
    • 9.3.2 Product Portfolio
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Company D
    • 9.4.1 Business Overview
    • 9.4.2 Product Portfolio
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Company E
    • 9.5.1 Business Overview
    • 9.5.2 Product Portfolio
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events

10 Japan Biomaterials Market - Industry Analysis

  • 10.1 Drivers, Restraints and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix